Compare FOSL & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOSL | RCEL |
|---|---|---|
| Founded | 1984 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 418.7M | 403.3M |
| IPO Year | 1994 | 2018 |
| Metric | FOSL | RCEL |
|---|---|---|
| Price | $6.47 | $15.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $9.25 | ★ $13.47 |
| AVG Volume (30 Days) | ★ 739.8K | 340.7K |
| Earning Date | 11-10-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.26 | ★ 27.20 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,004,406,000.00 | $71,610,000.00 |
| Revenue This Year | N/A | $23.37 |
| Revenue Next Year | $1.39 | $29.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 11.45 |
| 52 Week Low | $1.70 | $3.22 |
| 52 Week High | $7.39 | $15.64 |
| Indicator | FOSL | RCEL |
|---|---|---|
| Relative Strength Index (RSI) | 49.30 | 77.46 |
| Support Level | $3.83 | $3.86 |
| Resistance Level | $6.50 | N/A |
| Average True Range (ATR) | 0.34 | 0.81 |
| MACD | -0.10 | 0.11 |
| Stochastic Oscillator | 1.08 | 88.15 |
Fossil Group Inc is a design, innovation, and distribution company in consumer fashion accessories, offering products such as watches, jewelry, handbags, small leather goods, belts, and sunglasses. It designs, develops, markets, and distributes products under its owned brands FOSSIL, SKAGEN, MICHELE, RELIC, and ZODIAC. It operates through Americas, Europe, and Asia segments, each including sales to wholesale and distributor customers, as well as Company-owned retail stores and e-commerce activities based on the location of the selling entity. The Americas segment contributes the majority of revenue and includes sales across Canada, Latin America, and the United States, while the Europe and Asia segments cover their respective regions. Each segment provides similar products and services.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.